Journal Home
Search for

Volume 54, Issue 8, Pages 749-756 (August 2009)


View previous. 8 of 13 View next.

Trehalose inhibits inflammatory cytokine production by protecting IκB-α reduction in mouse peritoneal macrophages

Kahoru Tayaa, Kimiharu HirosebCorresponding Author Informationemail address, Setsuo Hamadaa

Accepted 3 May 2009.

Abstract 

Objective

The aim of this study was to examine whether trehalose, a disaccharide, could inhibit Porphyromonas gingivalis (P. gingivalis) lipopolysaccharide (LPS)-enhanced production of inflammatory cytokines in mouse peritoneal macrophages.

Design

Mouse peritoneal macrophages were treated with trehalose and stimulated with P. gingivalis LPS. Interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) levels in the culture supernatant were measured by ELISA. The mRNA levels of the cytokines in macrophages were analysed by semi-quantitative RT-PCR. DNA and protein synthesis were measured by incorporation of [3H] thymidine or [14C] praline into mouse peritoneal macrophages. IκB-α reductions were assessed by western blot.

Results

Treatment with trehalose suppressed LPS-induced IL-1β and TNF-α production and downregulated transcription of these cytokines. Furthermore, trehalose inhibited LPS-induced reduction of IκB-α. In addition, we also observed expression of the trehalose receptor (T1R3) in mouse peritoneal macrophages.

Conclusion

These results may suggest that trehalose inhibits LPS-induced production of IL-1β and TNF-α in mouse peritoneal macrophages by inhibiting degradation of IκB-α via the trehalose receptor T1R3.

a Division of Dental Pharmacology, Department of Oral Medical Science, Ohu University School of Dentistry, Koriyama, Fukushima 963-8611, Japan

b Division of Preventive Dentistry, Department of Oral Health, Ohu University School of Dentistry, Koriyama, Japan

Corresponding Author InformationCorresponding author. Tel.: +81 24 932 8982; fax: +81 24 932 8983.

PII: S0003-9969(09)00119-8

doi:10.1016/j.archoralbio.2009.05.003


View previous. 8 of 13 View next.